Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial-Reference-Cited by-同舟云学术

Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial

Published:2018-02-12 Issue:6 Volume:7 Page:e1428157
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Michels Judith¹²,Becker Natalia³,Suciu Stefan⁴,Kaiser Iris⁵,Benner Axel³,Kosaloglu-Yalcin Zeynep⁶,Agoussi Sandrine⁷,Halama Niels⁵,Pawlita Michael⁸,Waterboer Tim⁸,Eichmüller Stefan B.⁹^ORCID,Jäger Dirk⁵⁶,Eggermont Alexander M. M.¹²,Zörnig Inka⁵

Affiliation:

1. Department of Medical Oncology, Gustave Roussy Comprehensive Cancer Center, Villejuif/Paris-Sud, France

2. Université Paris-Sud, Kremlin Bicêtre, Paris, France

3. Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany

4. European Organisation for Research and Treatment of Cancer, Brussels, Belgium

5. Department of Medical Oncology, National Center for Tumor Diseases, Internal Medicine VI, Heidelberg University Hospital, Heidelberg, Germany

6. Clincial Cooperation Unit “Applied Tumor Immunity”, German Cancer Research Center (DKFZ), Heidelberg, Germany

7. INSERM U981, Gustave Roussy Comprehensive Cancer Center, Villejuif/Paris-Sud, France

8. Division of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center (DKFZ), Heidelberg, Germany

9. GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany

Funder

German Cancer Research Center

Gustave Roussy Comprehensive Cancer Center

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1428157

Reference50 articles.

1. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

2. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.

3. T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response

4. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines;Biotechnology Advances;2023-07

2. B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma;Nature Communications;2023-06-08

3. Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients;OncoImmunology;2022-10-05

4. Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma;Marine Drugs;2022-06-14